Cite
HARVARD Citation
Xu, W. et al. (n.d.). Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models. Journal for immunotherapy of cancer. p. . [Online].